138 related articles for article (PubMed ID: 19705478)
41. Chronic progressive external ophthalmoplegia with inflammatory myopathy.
Chen T; Pu C; Shi Q; Wang Q; Cong L; Liu J; Luo H; Fei L; Tang W; Yu S
Int J Clin Exp Pathol; 2014; 7(12):8887-92. PubMed ID: 25674260
[TBL] [Abstract][Full Text] [Related]
42. Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.
Horga A; Pitceathly RD; Blake JC; Woodward CE; Zapater P; Fratter C; Mudanohwo EE; Plant GT; Houlden H; Sweeney MG; Hanna MG; Reilly MM
Brain; 2014 Dec; 137(Pt 12):3200-12. PubMed ID: 25281868
[TBL] [Abstract][Full Text] [Related]
43. Clinical and molecular features of adPEO due to mutations in the Twinkle gene.
Lewis S; Hutchison W; Thyagarajan D; Dahl HH
J Neurol Sci; 2002 Sep; 201(1-2):39-44. PubMed ID: 12163192
[TBL] [Abstract][Full Text] [Related]
44. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
Di Fonzo A; Bordoni A; Crimi M; Sara G; Del Bo R; Bresolin N; Comi GP
Hum Mutat; 2003 Dec; 22(6):498-9. PubMed ID: 14635118
[TBL] [Abstract][Full Text] [Related]
45. Novel mitochondrial tRNA(Ile) m.4282A>G gene mutation leads to chronic progressive external ophthalmoplegia plus phenotype.
Jackson CB; Neuwirth C; Hahn D; Nuoffer JM; Frank S; Gallati S; Schaller A
Br J Ophthalmol; 2014 Oct; 98(10):1453-9. PubMed ID: 25034047
[TBL] [Abstract][Full Text] [Related]
46. A novel mitochondrial tRNAGlu (MTTE) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle.
Alston CL; Lowe J; Turnbull DM; Maddison P; Taylor RW
J Neurol Sci; 2010 Nov; 298(1-2):140-4. PubMed ID: 20810132
[TBL] [Abstract][Full Text] [Related]
47. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene.
Siciliano G; Tessa A; Petrini S; Mancuso M; Bruno C; Grieco GS; Malandrini A; DeFlorio L; Martini B; Federico A; Nappi G; Santorelli FM; Murri L
Neuromuscul Disord; 2003 Feb; 13(2):162-5. PubMed ID: 12565915
[TBL] [Abstract][Full Text] [Related]
48. Distinct segregation of the pathogenic m.5667G>A mitochondrial tRNA
Schlapakow E; Peeva V; Zsurka G; Jeub M; Wabbels B; Kornblum C; Kunz WS
Neuromuscul Disord; 2019 May; 29(5):358-367. PubMed ID: 30962064
[TBL] [Abstract][Full Text] [Related]
49. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement.
Van Goethem G; Luoma P; Rantamäki M; Al Memar A; Kaakkola S; Hackman P; Krahe R; Löfgren A; Martin JJ; De Jonghe P; Suomalainen A; Udd B; Van Broeckhoven C
Neurology; 2004 Oct; 63(7):1251-7. PubMed ID: 15477547
[TBL] [Abstract][Full Text] [Related]
50. Progressive external ophthalmoplegia and multiple mitochondrial DNA deletions.
Van Goethem G; Martin JJ; Van Broeckhoven C
Acta Neurol Belg; 2002 Mar; 102(1):39-42. PubMed ID: 12094562
[TBL] [Abstract][Full Text] [Related]
51. C10ORF2 mutation associated with progressive external ophthalmoplegia and clinically isolated syndrome.
Galassi G; Maggi L; Lamantea E; Ariatti A; Malagoli M
Acta Neurol Belg; 2017 Dec; 117(4):947-949. PubMed ID: 28528470
[No Abstract] [Full Text] [Related]
52. The V368i mutation in Twinkle does not segregate with AdPEO.
Arenas J; Briem E; Dahl H; Hutchison W; Lewis S; Martin MA; Spelbrink H; Tiranti V; Jacobs H; Zeviani M
Ann Neurol; 2003 Feb; 53(2):278. PubMed ID: 12557300
[No Abstract] [Full Text] [Related]
53. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia.
Van Goethem G; Martin JJ; Dermaut B; Löfgren A; Wibail A; Ververken D; Tack P; Dehaene I; Van Zandijcke M; Moonen M; Ceuterick C; De Jonghe P; Van Broeckhoven C
Neuromuscul Disord; 2003 Feb; 13(2):133-42. PubMed ID: 12565911
[TBL] [Abstract][Full Text] [Related]
54. Structure-function defects of the TWINKLE linker region in progressive external ophthalmoplegia.
Korhonen JA; Pande V; Holmlund T; Farge G; Pham XH; Nilsson L; Falkenberg M
J Mol Biol; 2008 Mar; 377(3):691-705. PubMed ID: 18279890
[TBL] [Abstract][Full Text] [Related]
55. Abnormal H-Tfam in a patient harboring a single mtDNA deletion.
Tessa A; Manca ML; Mancuso M; Renna MR; Murri L; Martini B; Santorelli FM; Siciliano G
Funct Neurol; 2000; 15(4):211-4. PubMed ID: 11213524
[TBL] [Abstract][Full Text] [Related]
56. A novel mutation (8342G-->A) in the mitochondrial tRNA(Lys) gene associated with progressive external ophthalmoplegia and myoclonus.
Tiranti V; Carrara F; Confalonieri P; Mora M; Maffei RM; Lamantea E; Zeviani M
Neuromuscul Disord; 1999 Mar; 9(2):66-71. PubMed ID: 10220860
[TBL] [Abstract][Full Text] [Related]
57. Differential phenotypes of active site and human autosomal dominant progressive external ophthalmoplegia mutations in Drosophila mitochondrial DNA helicase expressed in Schneider cells.
Matsushima Y; Kaguni LS
J Biol Chem; 2007 Mar; 282(13):9436-9444. PubMed ID: 17272269
[TBL] [Abstract][Full Text] [Related]
58. A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia.
Souilem S; Chebel S; Mancuso M; Petrozzi L; Siciliano G; FrihAyed M; Hentati F; Amouri R
J Neurol Sci; 2011 Jan; 300(1-2):187-90. PubMed ID: 20884012
[TBL] [Abstract][Full Text] [Related]
59. SLC25A4 and C10ORF2 Mutations in Autosomal Dominant Progressive External Ophthalmoplegia.
Park KP; Kim HS; Kim ES; Park YE; Lee CH; Kim DS
J Clin Neurol; 2011 Mar; 7(1):25-30. PubMed ID: 21519523
[TBL] [Abstract][Full Text] [Related]
60. Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA.
Hedermann G; Dahlqvist JR; Løkken N; Vissing CR; Knak KL; Andersen LK; Thomsen C; Vissing J
Neuromuscul Disord; 2018 May; 28(5):408-413. PubMed ID: 29567350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
